[{"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-001", "question": "A 58-year-old woman with hypertrophic cardiomyopathy presents with progressive dyspnea and New York Heart Association class III symptoms despite maximum tolerated doses of metoprolol and verapamil. Echocardiography reveals a resting left ventricular outflow tract (LVOT) gradient of 85 mmHg, septal thickness of 22 mm, and systolic anterior motion of the mitral valve with moderate mitral regurgitation. She has no coronary artery disease on angiography. The septal perforator anatomy is suitable for intervention. Which of the following findings would most strongly favor surgical myectomy over alcohol septal ablation in this patient?", "options": ["Concomitant intrinsic mitral valve disease requiring repair", "Patient preference for less invasive procedure", "Presence of atrial fibrillation requiring maze procedure consideration", "Septal thickness greater than 20 mm", "Age greater than 55 years"], "answer": "A", "answer_index": 0, "explanation": "Surgical myectomy is preferred over alcohol septal ablation when concomitant cardiac pathology requiring surgical correction exists, such as intrinsic mitral valve disease (leaflet abnormalities, chordal pathology) needing repair or replacement. While septal thickness >30mm and unsuitable coronary anatomy favor surgery, 22mm thickness alone does not preclude ablation. Atrial fibrillation can be addressed with catheter ablation. Age and patient preference, while considerations, are not absolute indications for one approach over another.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V (Valid). Verdict: Correct best answer. Key stem clues: 58-year-old woman with obstructive HCM, severe 85 mmHg LVOT gradient despite maximal beta-blocker and verapamil therapy, septal thickness 22 mm, SAM-related moderate MR, suitable septal perforator anatomy for ablation. The question asks which finding would most strongly favor surgical myectomy. Option A (concomitant intrinsic mitral valve disease requiring repair) is the established Class I indication for surgery per 2020 ACC/AHA HCM guidelines, as alcohol ablation cannot address primary valvular pathology. The stem correctly distinguishes SAM-related MR from intrinsic disease, making A a valid hypothetical discriminator. Alternative B (patient preference) would favor less invasive ablation, not surgery. Option C (AF) is weaker since catheter maze is an effective alternative. Option D (septal thickness >20 mm) is not discriminatory; surgery is favored when thickness exceeds 30 mm. Option E (age >55) is not a primary determinant. No internal contradictions; options permit clear discrimination with one best answer. Medical accuracy: fully consistent with current guideline-based management of obstructive HCM and multimodality treatment algorithms. Minimal fix: None required.\",\"medical_accuracy_score\":  \t\"5\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). Verdict: Correct best answer. Key stem clues: 58-year-old woman with obstructive HCM, severe 85 mmHg LVOT gradient despite maximal beta-blocker and verapamil therapy, septal thickness 22 mm, SAM-related moderate MR, suitable septal perforator anatomy for ablation. The question asks which finding would most strongly favor surgical myectomy. Option A (concomitant intrinsic mitral valve disease requiring repair) is the established Class I indication for surgery per 2020 ACC/AHA HCM guidelines, as alcohol ablation cannot address primary valvular pathology. The stem correctly distinguishes SAM-related MR from intrinsic disease, making A a valid hypothetical discriminator. Alternative B (patient preference) would favor less invasive ablation, not surgery. Option C (AF) is weaker since catheter maze is an effective alternative. Option D (septal thickness >20 mm) is not discriminatory; surgery is favored when thickness exceeds 30 mm. Option E (age >55) is not a primary determinant. No internal contradictions; options permit clear discrimination with one best answer. Medical accuracy: fully consistent with current guideline-based management of obstructive HCM and multimodality treatment algorithms. Minimal fix: None required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-002", "question": "A 6-year-old boy presents with recurrent episodes of weakness and dark urine following viral illnesses. Laboratory studies during an acute episode show: serum creatine kinase 45,000 U/L, myoglobinuria, and non-ketotic hypoglycemia with inappropriately low free fatty acids. Acylcarnitine profile shows elevated C14:1 and C14:2 species. Genetic testing confirms compound heterozygous mutations in ACADVL. Which of the following dietary modifications is most critical for preventing future metabolic crises?", "options": ["Strict avoidance of medium-chain triglycerides", "Supplementation with odd-chain fatty acids", "Restriction of long-chain fatty acids with medium-chain triglyceride supplementation", "High-protein diet with branched-chain amino acid supplementation", "Carnitine supplementation with unrestricted fat intake"], "answer": "C", "answer_index": 2, "explanation": "ACADVL mutations cause very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency, a disorder of long-chain fatty acid oxidation. Management requires restriction of long-chain fatty acids (which cannot be metabolized) and supplementation with medium-chain triglycerides (MCTs), which bypass the defective enzyme and provide an alternative energy source. MCT avoidance would be harmful. Carnitine supplementation alone without dietary modification is insufficient, and high-protein diets do not address the underlying metabolic defect.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V (Valid). Verdict: Correct best answer. The stem establishes VLCAD deficiency through classic clues: exertional weakness with myoglobinuria (CK 45,000 U/L), non-ketotic hypoglycemia with low free fatty acids, diagnostic acylcarnitine profile (elevated C14:1/C14:2), and confirmatory ACADVL genotyping. The question targets the cornerstone dietary therapy. Option C—restriction of long-chain fatty acids with medium-chain triglyceride (MCT) supplementation—is unequivocally the standard of care, providing substrate that bypasses the defective VLCAD enzyme via intact medium-chain pathways. Alternative critique: A is contraindicated (MCTs are therapeutic), B is nonstandard, D misdirects to protein metabolism, and E is insufficient (carnitine alone doesn't correct oxidation block). No logical defects: the stem furnishes adequate diagnostic certainty, options are mutually exclusive and discriminating, and the key aligns with consensus management. Medical accuracy: Gold-standard representation of VLCAD deficiency pathophysiology and evidence-based treatment per ACMG/GLIMD guidelines. No inaccuracies or outdated concepts. Minimal fix: None required.\",\n\"medical_accuracy_score\":    \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The stem establishes VLCAD deficiency through classic clues: exertional weakness with myoglobinuria (CK 45,000 U/L), non-ketotic hypoglycemia with low free fatty acids, diagnostic acylcarnitine profile (elevated C14:1/C14:2), and confirmatory ACADVL genotyping. The question targets the cornerstone dietary therapy. Option C—restriction of long-chain fatty acids with medium-chain triglyceride (MCT) supplementation—is unequivocally the standard of care, providing substrate that bypasses the defective VLCAD enzyme via intact medium-chain pathways. Alternative critique: A is contraindicated (MCTs are therapeutic), B is nonstandard, D misdirects to protein metabolism, and E is insufficient (carnitine alone doesn't correct oxidation block). No logical defects: the stem furnishes adequate diagnostic certainty, options are mutually exclusive and discriminating, and the key aligns with consensus management. Medical accuracy: Gold-standard representation of VLCAD deficiency pathophysiology and evidence-based treatment per ACMG/GLIMD guidelines. No inaccuracies or outdated concepts. Minimal fix: None required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-003", "question": "A 34-year-old woman with systemic lupus erythematosus on hydroxychloroquine and mycophenolate presents with acute onset severe headache, confusion, and seizures. Blood pressure is 168/102 mmHg. MRI brain shows bilateral posterior white matter T2/FLAIR hyperintensities without restricted diffusion. Lumbar puncture shows normal opening pressure, 8 WBC/μL (lymphocyte predominant), protein 52 mg/dL, and negative cultures. Anti-ribosomal P antibodies are positive. Which additional finding would most strongly suggest neuropsychiatric lupus rather than posterior reversible encephalopathy syndrome (PRES)?", "options": ["Presence of anti-dsDNA antibodies at high titer", "Low complement C3 and C4 levels", "Elevated CSF IgG index with oligoclonal bands", "Resolution of MRI findings with blood pressure control", "Concurrent lupus nephritis flare"], "answer": "C", "answer_index": 2, "explanation": "Elevated CSF IgG index with oligoclonal bands indicates intrathecal immunoglobulin synthesis, strongly supporting CNS inflammation from neuropsychiatric lupus (NPSLE) rather than PRES, which is a vasogenic edema syndrome without primary CNS inflammation. Anti-dsDNA antibodies and low complements indicate systemic lupus activity but don't differentiate CNS involvement. Resolution with BP control would actually favor PRES. Concurrent nephritis indicates systemic activity but doesn't confirm CNS-specific disease.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: 34-year-old woman with SLE on immunosuppression presenting with acute headache, confusion, and seizures; hypertension present; MRI shows bilateral posterior white matter T2/FLAIR hyperintensities without restricted diffusion—a pattern seen in both PRES and NPSLE; CSF reveals mild lymphocytic pleocytosis (8 WBC) and elevated protein (52 mg/dL) without infection; anti-ribosomal P antibodies are positive but not definitive for active neuropsychiatric disease. The question seeks the finding that most strongly suggests NPSLE over PRES. Option C (elevated CSF IgG index with oligoclonal bands) is uniquely defensible as it demonstrates intrathecal immunoglobulin synthesis, a hallmark of CNS inflammation in NPSLE, while PRES is a vasogenic edema syndrome without primary CNS inflammatory response. Options A, B, and E indicate systemic lupus activity but lack CNS specificity. Option D would paradoxically support PRES. No logical inconsistencies or medical inaccuracies are present. Minimal fix: None required; the item is well-constructed and discriminates appropriately.\",\n\"medical_accuracy_score\":    \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: 34-year-old woman with SLE on immunosuppression presenting with acute headache, confusion, and seizures; hypertension present; MRI shows bilateral posterior white matter T2/FLAIR hyperintensities without restricted diffusion—a pattern seen in both PRES and NPSLE; CSF reveals mild lymphocytic pleocytosis (8 WBC) and elevated protein (52 mg/dL) without infection; anti-ribosomal P antibodies are positive but not definitive for active neuropsychiatric disease. The question seeks the finding that most strongly suggests NPSLE over PRES. Option C (elevated CSF IgG index with oligoclonal bands) is uniquely defensible as it demonstrates intrathecal immunoglobulin synthesis, a hallmark of CNS inflammation in NPSLE, while PRES is a vasogenic edema syndrome without primary CNS inflammatory response. Options A, B, and E indicate systemic lupus activity but lack CNS specificity. Option D would paradoxically support PRES. No logical inconsistencies or medical inaccuracies are present. Minimal fix: None required; the item is well-constructed and discriminates appropriately.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-004", "question": "A 52-year-old man with type 2 diabetes presents for evaluation of recurrent hypoglycemia occurring 3-4 hours postprandially. He underwent Roux-en-Y gastric bypass 2 years ago with 45 kg weight loss. During a symptomatic episode, laboratory studies show: glucose 38 mg/dL, insulin 45 μU/mL (elevated), C-peptide 8.2 ng/mL (elevated), proinsulin 22 pmol/L (elevated), and negative sulfonylurea screen. Calcium-stimulated angiography localizes insulin secretion to the body and tail of the pancreas. Which of the following is the most appropriate next step in management?", "options": ["Distal pancreatectomy", "Diazoxide therapy", "Octreotide therapy", "Dietary modification with acarbose", "Enucleation of insulinoma"], "answer": "D", "answer_index": 3, "explanation": "This presentation is classic for post-gastric bypass hyperinsulinemic hypoglycemia (nesidioblastosis/non-insulinoma pancreatogenous hypoglycemia syndrome). Unlike insulinoma, this involves diffuse islet cell hyperfunction. First-line management is dietary modification (low glycemic index, frequent small meals) combined with acarbose to slow carbohydrate absorption and blunt the exaggerated incretin response. Distal pancreatectomy is reserved for refractory cases. The diffuse localization on angiography and post-bypass context argue against focal insulinoma requiring enucleation.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V (Valid). Verdict: Correct best answer. Key stem clues: post-Roux-en-Y gastric bypass, 3-4 hour postprandial hypoglycemia, elevated insulin/C-peptide/proinsulin with negative sulfonylurea screen, and diffuse insulin secretion on calcium-stimulated angiography. These findings define non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS) from islet hyperplasia, not a focal insulinoma. The question asks for the most appropriate next step. Option D (dietary modification with acarbose) is the established first-line therapy to blunt the exaggerated incretin response and slow carbohydrate absorption. Alternative options are incorrect: distal pancreatectomy (A) is reserved for refractory cases; diazoxide (B) and octreotide (C) are second-line medical therapies; enucleation (E) is inappropriate for diffuse disease. No logical flaws: the stem provides sufficient discriminators, options are distinct, and the key matches the single best answer. Medical accuracy is excellent: the pathophysiology, diagnostic approach, and management align with Endocrine Society guidelines and current literature on post-bariatric hypoglycemia. The teaching point is clear and clinically relevant. Minimal fix: None required.\",\n\"medical_accuracy_score\":   \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. Key stem clues: post-Roux-en-Y gastric bypass, 3-4 hour postprandial hypoglycemia, elevated insulin/C-peptide/proinsulin with negative sulfonylurea screen, and diffuse insulin secretion on calcium-stimulated angiography. These findings define non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS) from islet hyperplasia, not a focal insulinoma. The question asks for the most appropriate next step. Option D (dietary modification with acarbose) is the established first-line therapy to blunt the exaggerated incretin response and slow carbohydrate absorption. Alternative options are incorrect: distal pancreatectomy (A) is reserved for refractory cases; diazoxide (B) and octreotide (C) are second-line medical therapies; enucleation (E) is inappropriate for diffuse disease. No logical flaws: the stem provides sufficient discriminators, options are distinct, and the key matches the single best answer. Medical accuracy is excellent: the pathophysiology, diagnostic approach, and management align with Endocrine Society guidelines and current literature on post-bariatric hypoglycemia. The teaching point is clear and clinically relevant. Minimal fix: None required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-005", "question": "A 3-week-old male infant presents with poor feeding, lethargy, and hypotonia. He was born at term following an uncomplicated pregnancy. Physical examination reveals hepatomegaly, hypotonia, and macroglossia. Echocardiography shows severe biventricular hypertrophy with a left ventricular ejection fraction of 25%. Laboratory studies show elevated creatine kinase and AST. Urine organic acids are normal. Enzyme assay on dried blood spot shows markedly reduced acid alpha-glucosidase activity. Genetic testing confirms two pathogenic variants in GAA. Which of the following factors is most predictive of poor response to enzyme replacement therapy?", "options": ["Presence of cardiomyopathy at diagnosis", "Cross-reactive immunologic material (CRIM) negative status", "Age at diagnosis less than 1 month", "Elevated creatine kinase level", "Presence of macroglossia"], "answer": "B", "answer_index": 1, "explanation": "In infantile-onset Pompe disease, CRIM-negative status (complete absence of endogenous GAA protein) is the strongest predictor of poor response to enzyme replacement therapy (ERT) due to development of high-sustained antibody titers against the recombinant enzyme, which neutralize therapeutic effect. CRIM-negative patients require immune tolerance induction protocols. While early cardiomyopathy and young age at diagnosis indicate severe disease, CRIM-positive patients with these features can still respond well to ERT. Elevated CK and macroglossia are disease markers but not predictive of treatment response.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. Key stem clues: 3-week-old male with classic infantile-onset Pompe disease—cardiomyopathy (severe biventricular hypertrophy, LVEF 25%), hypotonia, macroglossia, hepatomegaly, elevated CK/AST, confirmed by deficient acid alpha-glucosidase and biallelic GAA pathogenic variants. The question targets prediction of enzyme replacement therapy (ERT) response. CRIM-negative status (complete absence of endogenous GAA protein) is uniquely associated with development of high-sustained anti-rhGAA IgG antibodies that neutralize therapeutic efficacy, making it the strongest predictor of poor outcome. Alternative options fail: cardiomyopathy and age <1 month indicate severity but not ERT responsiveness (CRIM-positive patients often respond well), while elevated CK and macroglossia are disease markers without predictive value. No logical flaws: stem provides adequate discriminatory context, options are comparable, and the key aligns with established consensus. Medical accuracy is gold-standard: CRIM status is the principal determinant of ERT response in infantile Pompe per current guidelines and natural history data. No contradictions or outdated information. Minimal fix: None required; item is board-examination ready.\",\"medical_accuracy_score\":  \"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. Key stem clues: 3-week-old male with classic infantile-onset Pompe disease—cardiomyopathy (severe biventricular hypertrophy, LVEF 25%), hypotonia, macroglossia, hepatomegaly, elevated CK/AST, confirmed by deficient acid alpha-glucosidase and biallelic GAA pathogenic variants. The question targets prediction of enzyme replacement therapy (ERT) response. CRIM-negative status (complete absence of endogenous GAA protein) is uniquely associated with development of high-sustained anti-rhGAA IgG antibodies that neutralize therapeutic efficacy, making it the strongest predictor of poor outcome. Alternative options fail: cardiomyopathy and age <1 month indicate severity but not ERT responsiveness (CRIM-positive patients often respond well), while elevated CK and macroglossia are disease markers without predictive value. No logical flaws: stem provides adequate discriminatory context, options are comparable, and the key aligns with established consensus. Medical accuracy is gold-standard: CRIM status is the principal determinant of ERT response in infantile Pompe per current guidelines and natural history data. No contradictions or outdated information. Minimal fix: None required; item is board-examination ready.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-006", "question": "A 67-year-old man with ischemic cardiomyopathy (LVEF 28%) and an implantable cardioverter-defibrillator presents after receiving three appropriate shocks for ventricular tachycardia over 24 hours despite amiodarone 400 mg daily. He is hemodynamically stable with blood pressure 102/68 mmHg. ECG shows sinus rhythm at 72 bpm with QTc 485 ms. Electrolytes and thyroid function are normal. Device interrogation confirms monomorphic VT at 188 bpm terminated by ATP and shocks. Which of the following is the most appropriate next step?", "options": ["Increase amiodarone to 600 mg daily", "Add mexiletine 200 mg three times daily", "Urgent catheter ablation of ventricular tachycardia", "Initiate dofetilide after appropriate QTc assessment", "Add ranolazine 500 mg twice daily"], "answer": "C", "answer_index": 2, "explanation": "This patient has electrical storm (≥3 sustained VT/VF episodes in 24 hours) refractory to amiodarone, which is a class I indication for urgent catheter ablation per current guidelines. Increasing amiodarone risks toxicity and QT prolongation. Adding mexiletine is reasonable for adjunctive therapy but does not address the substrate. Dofetilide is contraindicated with QTc >440ms in men and in the acute setting. Ranolazine has limited evidence for VT suppression. Catheter ablation targeting the VT substrate offers the best chance of preventing recurrent episodes.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The stem clearly establishes electrical storm (≥3 VT episodes in 24h) refractory to amiodarone in a patient with ischemic cardiomyopathy (LVEF 28%), ICD, hemodynamic stability, and QTc 485 ms. These clues uniquely point to urgent catheter ablation as the most appropriate next step—a class I indication per 2017 HRS/ACC/HRS ventricular arrhythmia guidelines. The keyed answer C is strongly supported: ablation targets the arrhythmogenic substrate and prevents recurrence. Alternative options are correctly constructed as less appropriate: A (increase amiodarone) risks toxicity and exacerbates QT prolongation; B (add mexiletine) is merely adjunctive without addressing substrate; D (dofetilide) is contraindicated with QTc >440 ms in men; E (ranolazine) lacks robust evidence for VT storm suppression. No logical flaws exist: the vignette provides adequate detail for single-best-answer selection, contains no internal contradictions, and the options permit clear discrimination. Medical accuracy is exemplary—content reflects current standard-of-care, guideline-concordant management. Minimal fix: none required; item is board-examination ready.\",\"medical_accuracy_score\":  \"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The stem clearly establishes electrical storm (≥3 VT episodes in 24h) refractory to amiodarone in a patient with ischemic cardiomyopathy (LVEF 28%), ICD, hemodynamic stability, and QTc 485 ms. These clues uniquely point to urgent catheter ablation as the most appropriate next step—a class I indication per 2017 HRS/ACC/HRS ventricular arrhythmia guidelines. The keyed answer C is strongly supported: ablation targets the arrhythmogenic substrate and prevents recurrence. Alternative options are correctly constructed as less appropriate: A (increase amiodarone) risks toxicity and exacerbates QT prolongation; B (add mexiletine) is merely adjunctive without addressing substrate; D (dofetilide) is contraindicated with QTc >440 ms in men; E (ranolazine) lacks robust evidence for VT storm suppression. No logical flaws exist: the vignette provides adequate detail for single-best-answer selection, contains no internal contradictions, and the options permit clear discrimination. Medical accuracy is exemplary—content reflects current standard-of-care, guideline-concordant management. Minimal fix: none required; item is board-examination ready.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-007", "question": "A 14-year-old girl presents with 6 months of progressive proximal muscle weakness, heliotrope rash, and Gottron papules. She has difficulty climbing stairs and raising her arms. Laboratory studies show CK 4,200 U/L and positive anti-MDA5 antibodies. Chest CT reveals subtle ground-glass opacities in bilateral lower lobes. Pulmonary function tests show FVC 72% predicted and DLCO 58% predicted. Muscle biopsy shows perifascicular atrophy. Which of the following findings most significantly increases her risk of rapidly progressive interstitial lung disease?", "options": ["Elevated serum ferritin level", "Presence of mechanic's hands", "Positive anti-Jo-1 antibodies", "Calcinosis cutis on examination", "Elevated aldolase level"], "answer": "A", "answer_index": 0, "explanation": "Anti-MDA5 antibody-positive dermatomyositis is associated with rapidly progressive interstitial lung disease (RP-ILD), which can be fatal. Elevated serum ferritin is a biomarker strongly associated with RP-ILD severity and poor prognosis in anti-MDA5 positive patients, reflecting macrophage activation. Anti-Jo-1 is associated with ILD but typically a more chronic course. Mechanic's hands are associated with antisynthetase syndrome. Calcinosis and elevated aldolase are features of juvenile DM but not specific predictors of RP-ILD in anti-MDA5 disease.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The stem's key discriminating features—anti-MDA5 antibody positivity, baseline ILD on CT/PFTs, and perifascicular atrophy—establish a high-risk phenotype for rapidly progressive interstitial lung disease (RP-ILD). Elevated serum ferritin (Option A) is the correct answer because it serves as a biomarker of macrophage activation syndrome and correlates strongly with RP-ILD severity and mortality in anti-MDA5 dermatomyositis, making it the most significant risk modifier among the choices. Each distractor is appropriately excluded: mechanic's hands (B) and anti-Jo-1 (C) define antisynthetase syndrome with typically chronic ILD; calcinosis cutis (D) is a juvenile DM feature lacking prognostic utility for pulmonary progression; elevated aldolase (E) merely reflects muscle inflammation without specificity for lung disease. No internal contradictions or underspecification prevent a single best answer. The item accurately reflects contemporary rheumatology literature and guideline-based teaching on MDA5-associated lung disease. Minimal fix: none required.\",\"medical_accuracy_score\":  \"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The stem's key discriminating features—anti-MDA5 antibody positivity, baseline ILD on CT/PFTs, and perifascicular atrophy—establish a high-risk phenotype for rapidly progressive interstitial lung disease (RP-ILD). Elevated serum ferritin (Option A) is the correct answer because it serves as a biomarker of macrophage activation syndrome and correlates strongly with RP-ILD severity and mortality in anti-MDA5 dermatomyositis, making it the most significant risk modifier among the choices. Each distractor is appropriately excluded: mechanic's hands (B) and anti-Jo-1 (C) define antisynthetase syndrome with typically chronic ILD; calcinosis cutis (D) is a juvenile DM feature lacking prognostic utility for pulmonary progression; elevated aldolase (E) merely reflects muscle inflammation without specificity for lung disease. No internal contradictions or underspecification prevent a single best answer. The item accurately reflects contemporary rheumatology literature and guideline-based teaching on MDA5-associated lung disease. Minimal fix: none required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-008", "question": "A 42-year-old woman presents to the emergency department with acute chest pain and dyspnea. She has a history of antiphospholipid syndrome with prior deep vein thrombosis, currently on warfarin with INR 2.8. ECG shows sinus tachycardia with new right bundle branch block. CT pulmonary angiography reveals bilateral pulmonary emboli with right ventricular dilation. Troponin I is 0.89 ng/mL. Blood pressure is 88/54 mmHg, heart rate 118 bpm. Despite 2 liters of crystalloid, blood pressure remains 84/52 mmHg. Which of the following is the most appropriate next step?", "options": ["Initiate unfractionated heparin infusion", "Administer systemic alteplase", "Perform catheter-directed thrombolysis", "Emergent surgical embolectomy", "Initiate norepinephrine and observe"], "answer": "B", "answer_index": 1, "explanation": "This patient has high-risk (massive) pulmonary embolism with hemodynamic instability (persistent hypotension despite fluid resuscitation) and RV dysfunction. Systemic thrombolysis with alteplase is the first-line treatment for hemodynamically unstable PE per guidelines, even in anticoagulated patients, as the mortality benefit outweighs bleeding risk. The therapeutic INR does not preclude thrombolysis in this life-threatening situation. Catheter-directed therapy or surgical embolectomy are alternatives if thrombolysis is contraindicated or fails. Simply adding vasopressors without addressing the obstruction is inadequate.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. This stem describes massive (high-risk) PE with hemodynamic instability (persistent SBP <90 mmHg despite 2L fluids), RV dysfunction (CT dilation, new RBBB, troponin 0.89 ng/mL), and therapeutic anticoagulation (INR 2.8). Key discriminating features are refractory hypotension and RV strain, mandating immediate reperfusion therapy. Systemic thrombolysis (B) is guideline-endorsed first-line treatment for massive PE per ACCP/ESC recommendations, even in anticoagulated patients, as mortality benefit outweighs bleeding risk. The therapeutic INR does not constitute contraindication in this life-threatening scenario. Alternatives are appropriately inferior: unfractionated heparin (A) is redundant given therapeutic INR and fails to address acute obstruction; catheter-directed thrombolysis (C) and surgical embolectomy (D) are rescue therapies for contraindication or failure, not first-line; norepinephrine with observation (E) is inadequate as sole therapy. No internal contradictions exist. The item permits clear discrimination and selects a single best answer consistent with standard-of-care. Medical accuracy is excellent and board-relevant. No revision required.\",\"medical_accuracy_score\":  \"5\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. This stem describes massive (high-risk) PE with hemodynamic instability (persistent SBP <90 mmHg despite 2L fluids), RV dysfunction (CT dilation, new RBBB, troponin 0.89 ng/mL), and therapeutic anticoagulation (INR 2.8). Key discriminating features are refractory hypotension and RV strain, mandating immediate reperfusion therapy. Systemic thrombolysis (B) is guideline-endorsed first-line treatment for massive PE per ACCP/ESC recommendations, even in anticoagulated patients, as mortality benefit outweighs bleeding risk. The therapeutic INR does not constitute contraindication in this life-threatening scenario. Alternatives are appropriately inferior: unfractionated heparin (A) is redundant given therapeutic INR and fails to address acute obstruction; catheter-directed thrombolysis (C) and surgical embolectomy (D) are rescue therapies for contraindication or failure, not first-line; norepinephrine with observation (E) is inadequate as sole therapy. No internal contradictions exist. The item permits clear discrimination and selects a single best answer consistent with standard-of-care. Medical accuracy is excellent and board-relevant. No revision required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-009", "question": "A 28-year-old woman with Graves' disease treated with methimazole 30 mg daily for 8 weeks presents with fever (39.2°C), severe sore throat, and malaise for 2 days. Physical examination reveals pharyngeal erythema without exudate and no lymphadenopathy. Complete blood count shows WBC 1,200/μL with absolute neutrophil count 80/μL, hemoglobin 13.2 g/dL, and platelets 245,000/μL. Which of the following is the most appropriate immediate management?", "options": ["Discontinue methimazole and initiate propylthiouracil", "Discontinue methimazole, obtain blood cultures, and initiate broad-spectrum antibiotics with G-CSF", "Continue methimazole at reduced dose with close monitoring", "Discontinue methimazole and proceed with urgent thyroidectomy", "Discontinue methimazole and initiate lithium carbonate"], "answer": "B", "answer_index": 1, "explanation": "This patient has methimazole-induced agranulocytosis (ANC <500/μL), a rare but life-threatening complication occurring in 0.1-0.5% of patients, typically within the first 3 months. Management requires immediate discontinuation of the offending thionamide (cross-reactivity precludes switching to PTU), blood cultures, broad-spectrum antibiotics covering Pseudomonas given febrile neutropenia, and G-CSF to accelerate neutrophil recovery. Continuing or reducing methimazole is dangerous. Urgent thyroidectomy in an agranulocytic patient carries prohibitive infection risk. Alternative thyroid control can be achieved with beta-blockers, iodine, or lithium after stabilization.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. Key stem clues: Graves' disease on methimazole 30 mg daily for 8 weeks; fever 39.2°C with severe sore throat; ANC 80/μL (agranulocytosis) with normal hemoglobin/platelets. This defines methimazole-induced agranulocytosis with febrile neutropenia. Option B correctly identifies immediate management: discontinue thionamide, obtain blood cultures, start broad-spectrum antibiotics, and give G-CSF. Alternative A fails due to thionamide cross-reactivity; C is unsafe continuation; D carries prohibitive infection risk and is not immediate; E addresses thyroid control but ignores the neutropenic emergency. No logical flaws: single best answer is clear, key matches it, and options permit discrimination. Medical accuracy is excellent: aligns with standard management of drug-induced agranulocytosis (stop offending drug, febrile neutropenia protocol, G-CSF). Minor nuance: G-CSF is strongly recommended in severe cases with infection. No fix required.\",\"medical_accuracy_score\":  \"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. Key stem clues: Graves' disease on methimazole 30 mg daily for 8 weeks; fever 39.2°C with severe sore throat; ANC 80/μL (agranulocytosis) with normal hemoglobin/platelets. This defines methimazole-induced agranulocytosis with febrile neutropenia. Option B correctly identifies immediate management: discontinue thionamide, obtain blood cultures, start broad-spectrum antibiotics, and give G-CSF. Alternative A fails due to thionamide cross-reactivity; C is unsafe continuation; D carries prohibitive infection risk and is not immediate; E addresses thyroid control but ignores the neutropenic emergency. No logical flaws: single best answer is clear, key matches it, and options permit discrimination. Medical accuracy is excellent: aligns with standard management of drug-induced agranulocytosis (stop offending drug, febrile neutropenia protocol, G-CSF). Minor nuance: G-CSF is strongly recommended in severe cases with infection. No fix required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-010", "question": "A 9-year-old boy with a history of Kawasaki disease at age 2 (treated with IVIG and aspirin, with documented giant coronary artery aneurysms) presents for routine cardiology follow-up. He is asymptomatic and active without limitations. Current medications include aspirin 81 mg daily and clopidogrel 75 mg daily. Echocardiography shows a 9 mm right coronary artery aneurysm (z-score +12) and 7 mm left anterior descending aneurysm (z-score +9). Stress MRI perfusion shows no inducible ischemia. Which of the following additional interventions is most strongly recommended based on current guidelines?", "options": ["Addition of warfarin with target INR 2.0-3.0", "Discontinuation of clopidogrel given no ischemia", "Annual exercise stress testing only", "Coronary CT angiography every 5 years", "Restriction from all competitive sports"], "answer": "A", "answer_index": 0, "explanation": "Giant coronary artery aneurysms (z-score ≥10 or absolute diameter ≥8mm) represent the highest risk category in Kawasaki disease and require triple antithrombotic therapy: aspirin, a second antiplatelet agent (clopidogrel), AND systemic anticoagulation with warfarin (target INR 2.0-3.0) or LMWH per AHA guidelines. This is due to high thrombotic risk within aneurysms. The absence of current ischemia does not reduce thrombotic risk. These patients require activity restriction from contact/collision sports but the antithrombotic intensification is the most critical missing intervention.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. This 9-year-old with a giant right coronary artery aneurysm (9mm, z-score +12) post-Kawasaki disease on dual antiplatelet therapy requires triple antithrombotic therapy per 2017 AHA guidelines. Key stem clues: definite giant aneurysm size (meets ≥8mm/z-score ≥10 threshold) and negative stress MRI. The absence of ischemia does not reduce thrombotic risk within the aneurysm. Keyed answer A (add warfarin INR 2.0-3.0) is uniquely defensible because systemic anticoagulation is mandatory for giant aneurysms. Alternative evaluation: B incorrectly discontinues indicated clopidogrel; C's surveillance-only approach is inadequate; D's CT every 5 years is insufficiently frequent (echo every 6-12 months is standard); E over-restricts activity beyond guideline recommendations (only contact/collision sports contraindicated). No logical flaws: stem provides sufficient data for single-best answer selection. Medical accuracy is gold-standard: precisely reflects current AHA recommendations. Minimal fix: none required.\",\"medical_accuracy_score\":  \"5\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. This 9-year-old with a giant right coronary artery aneurysm (9mm, z-score +12) post-Kawasaki disease on dual antiplatelet therapy requires triple antithrombotic therapy per 2017 AHA guidelines. Key stem clues: definite giant aneurysm size (meets ≥8mm/z-score ≥10 threshold) and negative stress MRI. The absence of ischemia does not reduce thrombotic risk within the aneurysm. Keyed answer A (add warfarin INR 2.0-3.0) is uniquely defensible because systemic anticoagulation is mandatory for giant aneurysms. Alternative evaluation: B incorrectly discontinues indicated clopidogrel; C's surveillance-only approach is inadequate; D's CT every 5 years is insufficiently frequent (echo every 6-12 months is standard); E over-restricts activity beyond guideline recommendations (only contact/collision sports contraindicated). No logical flaws: stem provides sufficient data for single-best answer selection. Medical accuracy is gold-standard: precisely reflects current AHA recommendations. Minimal fix: none required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]